eMedicine Specialties > Sports Medicine > Introductory Topics in Sports Medicine
Exercise-Induced Asthma: Follow-up
Updated: Jun 15, 2009
Follow-up
Return to Play
The severity of an EIA attack varies greatly. Although cases of respiratory arrest and even death have been reported, the usual scenario is of a mild respiratory difficulty during play, which either spontaneously resolves or immediately responds to inhaled albuterol. Oftentimes, the athlete self-medicates and never leaves play or alerts the trainer or doctor. Although no clear-cut guidelines exist, a player who is removed from play for an asthma attack should be kept out of play until his or her respiration has normalized. This should occur within 5-10 minutes of medication administration. The athlete should be monitored closely for signs of relapse over the next several hours. If the symptoms do not completely resolve with sideline medication, the athlete should not return to play and should be referred for further treatment. Depending on the severity of the patient's symptoms, this may require transportation via ambulance.
Complications
Complications of an untreated asthma attack include status asthmaticus, respiratory failure, and even death. More commonly, an anxiety attack can be precipitated secondary to dyspnea.
Prevention
The optimal treatment of EIA is to prevent the onset of symptoms. See the Medication section for a discussion of drugs used to prevent EIA.
Prognosis
The prognosis is excellent for athletes with asthma. With proper interventions, most symptoms can be prevented, and performance should not be limited by EIA if this condition is treated properly. Newly diagnosed young athletes need to be educated that this condition should not be perceived as an insurmountable disability. Using examples of the numerous elite athletes (eg, Jackie Joyner-Kersee [perhaps the world's greatest athlete]; Amy Van Dyken [Olympic swimmer]; Jerome Bettis [former running back for the Pittsburgh Steelers]) with this condition can help young impressionable athletes continue in their endeavors without fear of failure or medical distress.
Education
Patient education is a critical part of the treatment of EIA. Once the diagnosis is made, athletes should be encouraged to continue in their activities with the reassurance that proper treatment can allow for an unhampered performance for most individuals. In addition to reassurance, it is also important to teach individuals to recognize the signs of an impending attack. Once recognized, individuals should be taught to remove themselves from the aggravating activity and initiate treatment as necessary. This includes education about the proper choice of agents to abort an acute attack (ie, albuterol), but not cromolyn, salmeterol, or an inhaled steroid. Teaching the proper mechanics of inhalant medication administration is also important, along with, if needed, teaching and demonstrating the proper use of a spacer device to the patient; without the proper mechanics in using such devices, the medication does not reach the area of pathology and does not benefit the athlete.
For excellent patient education resources, visit eMedicine's Asthma Center. Also, see eMedicine's patient education articles Asthma, Asthma FAQs, and Exercise-Induced Asthma.
Miscellaneous
Medicolegal Pitfalls
- Downplaying of symptoms: The common pitfalls occur with downplaying of symptoms or patient complaints. Education of the coaching staff is crucial because coaches need to know that shortness of breath in athletes does not always indicate poor conditioning and that the consequences of ignoring an asthma attack can be serious.
- Missed diagnosis: The physician, trainer, or other medical staff must always consider bronchospasm in athletes with the previously described complaints. A high index of suspicion diminishes the possibility of missed diagnoses. A thorough knowledge of the differential diagnosis (see Differentials) and how to work up the possibilities are also important (see Workup).
Special Concerns
- Pregnancy: Although most of the commonly used drugs are in pregnancy category C, these agents are often used for asthma, which is a common condition of pregnancy.
- Pediatric population: Many of the agents used for asthma are not indicated for children younger than 2 years; other agents are not indicated for children younger than 6 years. However, these medications have been used successfully for decades in the management of childhood asthma and should be used for children with EIA.
- Other/general: The highly driven, high-performing adolescent athlete, especially the female athlete, is at high risk for vocal cord dysfunction. This condition can be confused with EIA but does not respond to the same treatment. Professionals caring for athletes must keep a high index of suspicion for vocal cord dysfunction.
More on Exercise-Induced Asthma |
| Overview: Exercise-Induced Asthma |
| Differential Diagnoses & Workup: Exercise-Induced Asthma |
| Treatment & Medication: Exercise-Induced Asthma |
Follow-up: Exercise-Induced Asthma |
| References |
| « Previous Page |
References
National Heart, Lung,and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3:Guidelines for the Diagnosis and Management of Asthma: Full Report 2007. Bethesda, Md: NHLBI; August 2007. Publication no. 07-4051. [Full Text].
Anderson SD. How does exercise cause asthma attacks?. Curr Opin Allergy Clin Immunol. Feb 2006;6(1):37-42. [Medline].
Hough DO, Dec KL. Exercise-induced asthma and anaphylaxis. Sports Med. Sep 1994;18(3):162-72. [Medline].
Beaudouin E, Renaudin JM, Morisset M, et al. Food-dependent exercise-induced anaphylaxis--update and current data. Allerg Immunol (Paris). Feb 2006;38(2):45-51. [Medline].
Stensrud T, Berntsen S, Carlsen KH. Exercise capacity and exercise-induced bronchoconstriction (EIB) in a cold environment. Respir Med. Jul 2007;101(7):1529-36. [Medline].
Butcher JD. Exercise-induced asthma in the competitive cold weather athlete. Curr Sports Med Rep. Dec 2006;5(6):284-8. [Medline].
Dickinson JW, Whyte GP, McConnell AK, Harries MG. Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods. Br J Sports Med. Feb 2006;40(2):179-82; discussion 179-82. [Medline].
Wilson JJ, Wilson EM. Practical management: vocal cord dysfunction in athletes. Clin J Sport Med. Jul 2006;16(4):357-60. [Medline].
Kenn K. [Vocal Cord Dysfunction--what do we really know? A review] [German]. Pneumologie. Jul 2007;61(7):431-9. [Medline].
Kaplan TA. Exercise challenge for exercise-induced bronchospasm: confirming presence, evaluating control. Phys Sports Med. 1995;23(8):47-57.
Rundell KW, Anderson SD, Spiering BA, Judelson DA. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest. Mar 2004;125(3):909-15. [Medline]. [Full Text].
Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother. Sep 2007;8(13):2173-87. [Medline].
Steinshamn S, Sandsund M, Sue-Chu M, Bjermer L. Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction. Chest. Oct 2004;126(4):1154-60. [Medline]. [Full Text].
Beuther DA, Martin RJ. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest. May 2006;129(5):1188-93. [Medline]. [Full Text].
Knöpfli BH, Luke-Zeitoun M, von Duvillard SP, et al. High incidence of exercise-induced bronchoconstriction in triathletes of the Swiss national team. Br J Sports Med. Aug 2007;41(8):486-91; discussion 491. [Medline].
[Best Evidence] Koh MS, Tee A, Lasserson TJ, Irving LB. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction. Cochrane Database Syst Rev. 2007;3:CD002739. [Medline].
Lacroix VJ. Exercise-induced asthma. Phys Sports Med. 1999;27(12):75-92.
McFadden ER Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med. May 12 1994;330(19):1362-7. [Medline].
National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002. Bethesda, Md: National Institutes of Health and National Heart, Lung, and Blood Institute; June 2003. NIH publication no. 02-5074. [Full Text].
Parsons JP, Kaeding C, Phillips G, ET AL. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc. Sep 2007;39(9):1487-92. [Medline].
Smith BW, MacKnight JM. Pulmonary. In: Safran MR, McKeag DB, Van Camp SP, eds. Manual of Sports Medicine. Vol 1. Philadelphia, Pa: Lippincott-Raven; 1998:244-9.
Storms WW. Asthma associated with exercise. Immunol Allergy Clin North Am. Feb 2005;25(1):31-43. [Medline].
Further Reading
Keywords
EIA, exertional asthma, exercise-induced bronchospasm, EIB, asthma, exercise-induced urticaria, allergic rhinitis, bronchoconstriction, exercise-related respiratory symptoms, wheezing, chest tightness, shortness of breath, dyspnea, difficulty breathing, aerobic exercise, environmental factors, allergic asthma, asthmogenic agents
Follow-up: Exercise-Induced Asthma